Implication of new models for predicting lung cancer screening selection based on CT scan and pathology image data |
Yuan Luo |
Northwestern University |
PLCO |
Dec 31, 2020 |
PLCO-710 |
Automated Medical Diagnostic Systems |
Fabien Scalzo |
University of California, Los Angeles (UCLA) |
PLCO |
Dec 29, 2020 |
PLCO-711 |
Multi-label Classification to Hierarchical Taxonomies for Lung |
cai chen |
Qingdao University of Science and Technology |
PLCO |
Dec 22, 2020 |
PLCOI-704 |
Development of improved pre-diagnostic biomarker-based screening algorithms for ovarian cancer |
Anna Lokshin |
UPMC Hillman Cancer Center |
PLCO |
Dec 22, 2020 |
2020-1020 |
Delineating the underlying reasons for the racial disparity in gastric cancer incidence in the United States. |
Haejin In |
Rutgers Cancer Institute |
PLCO |
Dec 22, 2020 |
2020-1002 |
Perfluoroalkyl Substances (PFASs) and Liver Cancer Risk in the United States |
Xuehong Zhang |
Harvard Medical School and Brigham and Women's Hospital |
PLCO |
Dec 22, 2020 |
2020-1001 |
Updates in lethal prostate cancer in the PLCO trial |
Jonathan Shoag |
Weill Cornell Medicine |
PLCO |
Dec 21, 2020 |
PLCO-701 |
Convolutional Survival Machines: Deep Convolutional Networks for Survival Analysis with Time-Varying risks. |
Artur Dubrawski |
Carnegie Mellon University |
PLCO |
Dec 21, 2020 |
PLCOI-706 |
Diabetes, antidiabetic medication use, and the risk of ovarian cancer |
Susan Steck |
University of South Carolina |
PLCO |
Dec 21, 2020 |
PLCO-705 |
Diabetes risk reduction diet and all-cause and cause-specific mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
Guo-Chao Zhong |
The Second Affiliated Hospital of Chongqing Medical University |
PLCO |
Dec 11, 2020 |
PLCO-700 |
Genome-wide Association Study of Colorectal Cancer Using Penalized Orthogonal Components Regression |
Min Zhang |
Purdue University |
PLCO |
Dec 2, 2020 |
PLCO-697 |
Dietary inflammatory index and colorectal carcinogenesis: a prospective cohort study |
Zhuyue Li |
Sichuan University |
PLCO |
Dec 2, 2020 |
PLCO-698 |
HDoCS in PLCO: Health Disparities of Cancer Survivors in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
Jacqueline Vo |
National Cancer Institute |
PLCO |
Dec 2, 2020 |
PLCO-696 |
Hormone replacement therapy use and risk of breast cancer incidence and death |
Yi Jiang |
Department of General Medicine and Geriatrics ,Chongqing University Central Hospital ,Chongqing Emergency Medical Center, China, 400000 |
PLCO |
Nov 19, 2020 |
PLCO-694 |
Applying Machine Learning on available datasets to derive knowledge |
Shalini Madhan |
st josephs college of engineering |
PLCO |
Nov 17, 2020 |
PLCO-690 |
Machine Learning for Colorectal Cancer Risk Prediction |
Ling Zheng |
Monmouth University |
PLCO |
Nov 17, 2020 |
PLCO-687 |
Evaluate the impact of ovarian cancer interventions for primary prevention, screening and treatment |
Iakovos Toumazis |
The University of Texas MD Anderson Cancer Center |
PLCO |
Nov 17, 2020 |
PLCO-689 |
Deep learning based cancer grading for early detection from histology image biostatistics |
Ahmet Coskun |
Georgia Institute of Technology |
PLCO |
Nov 17, 2020 |
PLCOI-695 |
Magnesium intake and colorectal cancer incidence and mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
Zhuyue Li |
Sichuan University |
PLCO |
Nov 17, 2020 |
PLCO-692 |
Using clinicopathological data to determine risk of metachronous advanced colorectal neoplasia among patients with adenomas |
Laura Hester |
Janssen Research and Development, LLC |
PLCO |
Nov 17, 2020 |
PLCO-688 |